Uterine papillary serous carcinoma (UPSC): a single institution review of 129 cases. - Wikidata - wikimedia - TriplyDB

Uterine papillary serous carcinoma (UPSC): a single institution review of 129 cases.

Uterine papillary serous carcinoma (UPSC): a single institution review of 129 cases.

http://www.wikidata.org/entity/Q35607764

about

HER2 expression beyond breast cancer: therapeutic implications for gynecologic malignancies Etiologic heterogeneity in endometrial cancer: evidence from a Gynecologic Oncology Group trial.Uterine serous carcinoma: increased familial risk for lynch-associated malignancies Cytologic findings of cervicovaginal smears in women with uterine papillary serous carcinoma.Improving oncologic outcomes for women with endometrial cancer: realigning our sights The incidence of pelvic and para-aortic lymph node metastasis in uterine papillary serous and clear cell carcinoma according to the SEER registry Clinicopathological characteristics and her-2/neu status in chinese patients with uterine papillary serous carcinoma erbB2 Overexpression in Uterine Serous Cancer: A Molecular Target for Trastuzumab Therapy.Primary sources of pelvic serous cancer in patients with endometrial intraepithelial carcinoma.Management of women with surgically staged 1 uterine papillary serous cancer.High-dose-rate vaginal brachytherapy with chemotherapy for surgically staged localized uterine serous carcinoma Characterization of precursor lesions in the endometrium and fallopian tube epithelium of early-stage uterine serous carcinoma Endometrial serous carcinoma (uterine papillary serous carcinoma): precancerous lesions and the theoretical promise of a preventive approach.Solitomab, an EpCAM/CD3 bispecific antibody construct (BiTE), is highly active against primary uterine serous papillary carcinoma cell lines in vitro.A prospective phase II study of chemoradiation followed by adjuvant chemotherapy for FIGO stage I-IIIA (1988) uterine papillary serous carcinoma of the endometrium.Uterine papillary serous carcinoma: a review.Tubulin-β-III overexpression by uterine serous carcinomas is a marker for poor overall survival after platinum/taxane chemotherapy and sensitivity to epothilones.Serous endometrial intraepithelial carcinoma: a case series and literature review Personalized care in uterine cancer.Adrenal Metastasis from Uterine Papillary Serous Carcinoma.Endometrial serous carcinoma: its molecular characteristics and histology-specific treatment strategies.HER2 gene amplification and EGFR expression in a large cohort of surgically staged patients with nonendometrioid (type II) endometrial cancer.Insights into endometrial serous carcinogenesis and progression.Molecular target therapies in endometrial cancer: from the basic research to the clinic.The clinical relevance of rising CA-125 levels within the normal range in patients with uterine papillary serous cancer The use of minimally invasive surgery for endometrial cancer.Cytoreductive surgery for advanced and recurrent endometrial cancer: a review of the literature.A clinical and pathologic comparison between stage-matched endometrial intraepithelial carcinoma and uterine serous carcinoma: is there a difference?Taxanes: their impact on gynecologic malignancy.Clinicopathologic study in uterine cancer.Clinical management of uterine papillary serous carcinoma.Emerging therapeutic targets in endometrial cancer.Class III b-tubulin overexpression in gynecologic tumors: implications for the choice of microtubule targeted agents?Lipocalin-2 and matrix metalloproteinase-9 expression in high-grade endometrial cancer and their prognostic value.Extent of lymphovascular space invasion may predict lymph node metastasis in uterine serous carcinoma.Factors prognostic of survival in advanced-stage uterine serous carcinoma.Uterine Cancer After Risk-Reducing Salpingo-oophorectomy Without Hysterectomy in Women With BRCA Mutations.Evaluation of adjuvant therapy in women with uterine papillary serous cancer.Should all patients with serous and clear cell endometrial carcinoma receive adjuvant chemotherapy?Subtype-specific mutation of PPP2R1A in endometrial and ovarian carcinomas.

P2860

Q26822730-7D26E36C-6DC2-4DBB-8F11-54015ACAAC1D Q30413346-80787BE6-44E6-499A-A646-8B100951FC43 Q30422098-0FB07BF5-DE40-4030-8363-2E8D4D8B8E75 Q33599423-8CA7242D-722F-4420-96F4-A8C3796AE0EB Q33926124-50613136-11AB-484A-A5BA-6DB0244908C4 Q34996956-FF8ECABD-32F7-4B10-9AEF-A66E1987E82E Q35007178-F913631A-C21A-46C7-846B-93E67447A27F Q35174196-002ACE47-51D6-4E13-A18B-D97A10122A7D Q35187272-382A44E2-B2BD-4B1F-8DB5-35B81AA567D8 Q35207926-B8084DDE-FB45-48E4-91DE-428C1ABB4C7A Q35210293-9031B4BB-6859-4146-AB07-9E916CA59DE7 Q35519808-31170C9A-E501-462F-B913-2A83F7CC2DC3 Q36003197-6B53E6EF-24FF-4961-9F5E-8EC4CE143974 Q36421292-466103D7-79BC-4C2E-A1D7-B0D86837BDF5 Q36737086-7173AB21-3550-4030-A57B-A4AF98E4E3A1 Q36787306-9B7C3D79-85BC-4E1A-9C24-C490163627D8 Q36980135-633B5628-6E45-4A05-B9A1-61079EB725D3 Q36991986-925D1E26-2A74-4AD2-A40D-2B8D595526D0 Q37006856-B8D2BFDA-3042-4597-BCAF-E2CFBD16BC86 Q37016964-7963BB32-EEB7-40F0-BEBA-0F7CD74967E4 Q37017041-1D490AE7-A4E7-4177-A3E3-49EE34462019 Q37080967-148E8D5D-D2BD-46E8-A5EA-A66754B083CA Q37127024-7089831C-9889-4572-8A66-40F9A0A04BD3 Q37196543-FA626A7B-8162-4735-9F6D-D73B56A4340D Q37296114-61DE3F00-71EA-4633-A069-EDE0FA9220DC Q37349630-3B350C14-B4C2-4414-9010-3C50BFA88999 Q37544846-EB71800C-2102-42F5-AC41-944C0FCC8D6A Q37651338-97E7489B-EF3C-4BDD-B303-D37BAC5DAFC7 Q37692801-B8D75FD4-552D-45E3-883A-E95474D2828E Q37709899-FD783E87-BEFF-4750-A200-9289D421C848 Q37821898-F65B703B-977E-4473-A538-131FDC2F46F9 Q37827340-E24AE287-213C-462F-941B-185F5C28CD93 Q38069185-50A4F4CE-E946-46E2-8871-1CA012ECCC12 Q38388732-5B639788-F5D1-40F6-B5FB-23FEA8300B2D Q38678448-86203EFC-EE95-4551-8958-66AA2B276C8D Q39278980-D794CFD9-3BEF-414F-956C-D6C4E031A96A Q39639274-6E98DD34-C93C-4A5D-8EB2-7F31FCD82688 Q39677120-7BA147E7-2233-4C1D-8DC6-71B8A1DCF8E8 Q39811675-A53AF8DC-F229-4609-B566-E865A61D26ED Q42816041-5AC1FC3A-5F34-47B3-B767-18456718680F

P2860

Uterine papillary serous carcinoma (UPSC): a single institution review of 129 cases.

http://www.wikidata.org/entity/Q35607764

description

2003 nî lūn-bûn

@nan

2003年の論文

@ja

2003年論文

@yue

2003年論文

@zh-hant

2003年論文

@zh-hk

2003年論文

@zh-mo

2003年論文

@zh-tw

2003年论文

@wuu

2003年论文

@zh

2003年论文

@zh-cn

name

Uterine papillary serous carcinoma (UPSC): a single institution review of 129 cases.

@ast

Uterine papillary serous carcinoma (UPSC): a single institution review of 129 cases.

@en

type

label

Uterine papillary serous carcinoma (UPSC): a single institution review of 129 cases.

@ast

Uterine papillary serous carcinoma (UPSC): a single institution review of 129 cases.

@en

prefLabel

Uterine papillary serous carcinoma (UPSC): a single institution review of 129 cases.

@ast

Uterine papillary serous carcinoma (UPSC): a single institution review of 129 cases.

@en

P1433

Q35607764-5D5DBFE6-3184-4DA0-8825-254E9E75C220

P1476

Q35607764-FA31BDCC-7ADE-4BE4-A004-1137EFE2532E

P2093

Q35607764-0E9AB3FE-2CE5-478B-A78A-20A6436B5ABD

Q35607764-3FA412DD-F404-4583-9CDF-B6FED960F063

Q35607764-4C2473BC-D8DC-4482-9A01-C1E2CE2B1EDD

Q35607764-67FE0620-ACA6-4DAD-9F8D-DDF55A6448CB

Q35607764-80699EC4-3CD8-4B73-B602-4A38750F5B2D

Q35607764-917E90AA-E71C-4128-A7C2-7D02A72D0207

Q35607764-A71B7B57-0B89-466B-9A43-760743D7DB6E

Q35607764-B17C26F3-A126-484D-AEF5-5F5861AD0000

Q35607764-BBD41D2C-7D19-4D63-BB41-8846C9E6C851

Q35607764-D5F563BA-EB4D-425E-9AD0-E5092724BE27

P304

Q35607764-2944652F-397D-4190-AF72-A24BD67ECB3D

P31

Q35607764-77b68768-29b9-4514-bef5-a119e5298b09

Q35607764-C28294B3-11E9-41CF-B64E-E66481C19462

P356

Q35607764-D05FF609-656D-4E9B-98BB-DE13B9A2B552

P407

Q35607764-8EC0F32B-0E9C-4702-AC0A-CF07859B728F

P433

Q35607764-F8A0911D-1492-4C55-B1AD-1829E83BD8C6

P478

Q35607764-24E09DFC-4BB3-4F2E-B7C5-3781ABEDF243

P577

Q35607764-7C9314B1-5D81-4F98-9C12-91DE8A1DB4C7

P698

Q35607764-F9A86897-2D1D-4B26-BD9E-64B0634644BD

P356

J.YGYNO.2003.08.018

P1433

Gynecologic Oncology

P1476

Uterine papillary serous carcinoma (UPSC): a single institution review of 129 cases.

@en

P2093

Anuja Jhingran

http://www.w3.org/2001/XMLSchema#string

Brian M Slomovitz

http://www.w3.org/2001/XMLSchema#string

David M Gershenson

http://www.w3.org/2001/XMLSchema#string

E Neely Atkinson

http://www.w3.org/2001/XMLSchema#string

Elvio G Silva

http://www.w3.org/2001/XMLSchema#string

Jonathan C Oh

http://www.w3.org/2001/XMLSchema#string

Karen H Lu

http://www.w3.org/2001/XMLSchema#string

Lois M Ramondetta

http://www.w3.org/2001/XMLSchema#string

Patricia J Eifel

http://www.w3.org/2001/XMLSchema#string

Russell R Broaddus

http://www.w3.org/2001/XMLSchema#string

P304

463-469

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1016/J.YGYNO.2003.08.018

http://www.w3.org/2001/XMLSchema#string

P407

P433

3

http://www.w3.org/2001/XMLSchema#string

P478

91

http://www.w3.org/2001/XMLSchema#string

P577

2003-12-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

14675663

http://www.w3.org/2001/XMLSchema#string